Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Biotech
  • Healthcare
  • Cleantech
  • Technology
  • Other

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • IP Venture Fund II
  • Top 10 Holdings
    by value
Medical Equipment & Supplies

University: Queen Mary

Company Stage: Quoted

Website: http://www.retroscreen.com

Retroscreen Virology is Europe's leading contract virology research company. The work it carries out is dedicated to creating the next generation of antivirals and vaccines in the field of biomedical research. Its research includes both pre-clinical and clinical projects. It currently conducts and co-ordinates several clinical trials per year involving student/staff volunteers or patients in general practice, particularly involving influenza or common cold viruses or vaccines.

As at 31 Dec 2013

IP Group holding

IP Venture Fund* holding

18.3%

7.5%
 

*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt

Retroscreen Virology

Related news

14 Jul 2014
26 Jun 2014

There is currently no news available.

More portfolio news